AI assistant
Sending…
TuHURA Biosciences, Inc./NV — Director's Dealing 2014
Feb 13, 2014
34026_dirs_2014-02-13_f4963b7a-626a-4e53-a1b3-87496a1f287c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DelMar Pharmaceuticals, Inc. (DMPI)
CIK: 0001498382
Period of Report: 2014-02-13
Reporting Person: BACHA JEFFREY (Director, CEO and PRESIDENT, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-02-13 | COMMON STOCK | P | 5000 | $.80 | Acquired | 27000 | Direct |
More from TuHURA Biosciences, Inc./NV
Capital/Financing Update
2026
May 29
Interim / Quarterly Report
2026
May 15
Report Publication Announcement
2026
May 15
Capital/Financing Update
2026
Apr 22
Capital/Financing Update
2026
Apr 8
Regulatory Filings
2026
Apr 8
Earnings Release
2026
Apr 1
Director's Dealing
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 17